Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0XTAZR
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
FDA022-BB05
|
|||||
| Synonyms |
Anti-HER2 ADC (Shanghai Fudan-Zhangjiang Bio-Pharmaceutical)
Click to Show/Hide
|
|||||
| Organization |
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
BB05 Platform.
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.